IPA Comments on Aduhelm NCD Infusion Providers Alliance2021-08-26T14:06:37+00:00 IPA Comments on Aduhelm NCDInfusion Providers Alliance2021-08-26T14:06:37+00:00
IPA Newsletter Infusion Providers Alliance2021-07-08T20:35:33+00:00 IPA NewsletterInfusion Providers Alliance2021-07-08T20:35:33+00:00
IPA Engages 4 MACs on Recent Downcoding of Complex Drug Infusions Infusion Providers Alliance2021-06-30T23:20:08+00:00 IPA Engages 4 MACs on Recent Downcoding of Complex Drug InfusionsInfusion Providers Alliance2021-06-30T23:20:08+00:00
Policy Positions for 2021 Rx Reform Bill Infusion Providers Alliance2024-08-27T13:40:31+00:00 Policy Positions for 2021 Rx Reform BillInfusion Providers Alliance2024-08-27T13:40:31+00:00
In the States Infusion Providers Alliance2021-05-02T20:54:56+00:00 In the StatesInfusion Providers Alliance2021-05-02T20:54:56+00:00
IPA Weighs in on Step Therapy for Part B Drugs in Medicare Advantage Infusion Providers Alliance2021-05-02T21:05:11+00:00 IPA Weighs in on Step Therapy for Part B Drugs in Medicare AdvantageInfusion Providers Alliance2021-05-02T21:05:11+00:00
IPA Comments on MFN Model Infusion Providers Alliance2021-01-27T13:59:49+00:00 IPA Comments on MFN ModelInfusion Providers Alliance2021-01-27T13:59:49+00:00
IPA Statement on MFN Interim Final Rule Infusion Providers Alliance2020-12-01T19:48:08+00:00 IPA Statement on MFN Interim Final RuleInfusion Providers Alliance2020-12-01T19:48:08+00:00
Letter to Anthem Infusion Providers Alliance2020-11-19T15:02:42+00:00 Letter to AnthemInfusion Providers Alliance2020-11-19T15:02:42+00:00
Congress Should Continue Suspension of Medicare Sequester Infusion Providers Alliance2021-02-12T16:53:41+00:00 Congress Should Continue Suspension of Medicare SequesterInfusion Providers Alliance2021-02-12T16:53:41+00:00
